We are live on ! Find out more
HARP

Harpoon Therapeutics, Inc. Common Stock
HARP

Delisted

HARP was delisted on the 8th of March, 2024.

Back to rankings

29 hedge funds and large institutions have $128M invested in Harpoon Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 29 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
+29
Holders Change %
–
% of All Funds
0.63%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
29
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MAM
MPM Asset Management
Massachusetts
+$59.5M
2
NLVP
New Leaf Venture Partners
New York
+$38.4M
3
O
OrbiMed
New York
+$32.2M
4
EC
EcoR1 Capital
California
+$17.6M
5
CAM
Cormorant Asset Management
Massachusetts
+$8.86M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
1
MPM Asset Management
Massachusetts
$42.8M +$59.5M +452,443 New
NLVP
2
New Leaf Venture Partners
New York
$27.7M +$38.4M +292,141 New
O
3
OrbiMed
New York
$23.2M +$32.2M +244,641 New
EC
4
EcoR1 Capital
California
$12.7M +$17.6M +133,642 New
CAM
5
Cormorant Asset Management
Massachusetts
$6.38M +$8.86M +67,389 New
SFM
6
Sphera Funds Management
Israel
$3.13M +$4.35M +33,080 New
FI
7
Fosun International
China
$3.06M +$4.25M +32,340 New
DM
8
Deerfield Management
New York
$2.7M +$3.75M +28,500 New
BBA
9
Baker Bros. Advisors
New York
$2.03M +$2.82M +21,429 New
Millennium Management
10
Millennium Management
New York
$1.2M +$1.66M +12,666 New
BlackRock
11
BlackRock
New York
$879K +$1.22M +9,281 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$783K +$1.09M +8,273 New
DIM
13
DC Investments Management
Virginia
$421K +$584K +4,444 New
Northern Trust
14
Northern Trust
Illinois
$309K +$429K +3,267 New
Charles Schwab
15
Charles Schwab
California
$286K +$396K +3,017 New
Goldman Sachs
16
Goldman Sachs
New York
$278K +$386K +2,936 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$110K +$154K +1,171 New
California State Teachers Retirement System (CalSTRS)
18
California State Teachers Retirement System (CalSTRS)
California
$38K +$52.3K +398 New
Deutsche Bank
19
Deutsche Bank
Germany
$28K +$41.5K +316 New
AIG
20
American International Group
New York
$15K +$21.6K +164 New
Barclays
21
Barclays
United Kingdom
$7K +$9.99K +76 New
JP Morgan Chase
22
JP Morgan Chase
New York
$6K +$8.15K +62 New
Citigroup
23
Citigroup
New York
$6K +$8.94K +68 New
Legal & General Group
24
Legal & General Group
United Kingdom
$6K +$8.94K +68 New
Bank of America
25
Bank of America
North Carolina
$5K +$6.57K +50 New
1
2

HARP Hedge Fund Activity: Q1 2019 in Review

29 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Harpoon Therapeutics, Inc. Common Stock (HARP) for Q1 2019, worth a combined $128M.

Buyers outnumbered sellers: 29 funds opened new HARP positions and 0 closed out — a net gain of 29 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was MPM Asset Management, opening a new position worth an estimated $59.5M.

  • 29 institutional investors held Harpoon Therapeutics, Inc. Common Stock (HARP) as of Q1 2019, up from 0 in Q4 2018.
  • Funds reported $128M of Harpoon Therapeutics, Inc. Common Stock stock for Q1 2019.
  • 29 funds opened new Harpoon Therapeutics, Inc. Common Stock positions in Q1 2019 and 0 closed out, a net change of +29 holders.
  • The largest Harpoon Therapeutics, Inc. Common Stock buyer in Q1 2019 was MPM Asset Management, an estimated $59.5M added.

Based on aggregated 13F filings for Q1 2019.